Image
Find out more about the impact of the molecular structure of Fc-containing bDMARDs
Back to top
Prof Lluís Puig
Director of Dermatology
Professor Lluís Puig is Director of Dermatology at the Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, and Professor of Dermatology at the University of Barcelona, Spain.
For over 15 years, Professor Puig’s clinical research has focused on the treatment of psoriasis with biological agents. He has worked on over 85 clinical trials and research projects, primarily as the principal investigator.
Professor Puig also serves on several editorial boards and has published over 300 papers in journals such as The New England Journal of Medicine, Journal of the European Academy of Dermatology and Venereology, and British Journal of Dermatology.
He is a member of multiple national and international scientific societies, has been a member of the board of directors of the European Academy of Dermatology and Venereology (EADV), and is co-Chair of the Psoriasis Task Force of the EADV, Member of the GRAPPA Education and Steering Committees, and Board Member of the International Psoriasis Council.
0 resources
Image
File
PsA patient consultation guide
Empower patients with PsA with this interactive guide to help them confidently prepare for appointments and support shared decision-making
EU-DA-2400146
Image
File
AxSpA patient consultation guide
Empower patients with axSpA with this interactive guide to help them confidently prepare for appointments and support shared decision-making
EU-DA-2400137
File
Support patients with this wound care guide including practical tips, dressing pros/cons and guidance for routine HS lesions
EU-DA-2500084
File
Master the new S2k HS guidelines. Download this quick guide for key updates and printable treatment algorithms to optimise patient care
EU-BK-2500037
Image
Video41:11 min
Navigating the new European S2k guidelines for hidradenitis suppurativa: How will they change your clinical practice?
Unlock the European S2k HS guidelines. Prof. Tzellos and Prof. Bechara share expert insights and implications of the updated guidelines
EU-BK-2500021